OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NOL60

NobleOak Life Ltd

Life & Health InsuranceVerified

NobleOak Life Ltd maintains a strong liquidity position, with cash and equivalents amounting to AUD 85.55 million, representing 15.07% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is 0.019, which is above the industry median of 0.015, indicating a robust ability to meet short-term obligations. The debt-to-equity ratio of 0.05 is significantly lower than the industry median of 0.25, suggesting a conservative capital structure with minimal leverage risk. Profitability metrics show a return on equity (ROE) of 8.0%, which is below the industry median of 10.5%, and a return on assets (ROA) of 1.25%, also below the industry median of 2.0%. These figures suggest that the company is generating returns, but at a slower pace compared to its peers. The operating margin of 2.72% is in line with the industry median of 2.6%, indicating that the company is managing its operating costs effectively. The company's revenue is distributed across three segments: Direct Business, Partnership, and Genus. The Direct Business segment, which sells life insurance products directly to customers under the NobleOak brand, is the largest contributor to revenue. The Partnership segment, which sells products through advisors under partner brands, and the Genus segment, which provides administration services, also contribute to the revenue mix. The geographic exposure is primarily concentrated in Australia, with no significant international operations disclosed. Looking at the growth trajectory, the company is projected to see a 4.5% increase in revenue in the current fiscal year and a 3.2% increase in the next fiscal year. This growth is driven by expansion in the Direct Business segment and continued performance in the Partnership segment. The company's operating income is expected to grow by 3.8% in the current fiscal year and 2.9% in the next fiscal year, reflecting a stable but moderate growth outlook. The risk assessment indicates a low liquidity risk, supported by the company's strong cash reserves and low debt levels. The dilution risk is also low, with no immediate filing-based liquidity or dilution flags detected. The company has not issued new shares recently, and there are no indications of near-term dilution pressure. The conservative capital structure and strong liquidity position further mitigate the risk of financial distress. Recent events include the company's continued focus on expanding its Direct Business segment and maintaining strong relationships with strategic partners. The company has not disclosed any major regulatory changes or legal challenges that could impact its operations. Analysts have provided a mean price target of AUD 2.93, with a median of AUD 2.85, indicating a generally positive outlook despite the absence of strong-buy recommendations.

30-day price · NOL+0.01 (+0.8%)
Low$1.15High$1.36Close$1.27As of19 May, 00:00 UTC
Profile
CompanyNobleOak Life Ltd
TickerNOL.AX
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. NobleOak Life Ltd is an Australia-based direct life insurer that offers life insurance products, including death, total and permanent disability, trauma, income protection, and business expenses insurance, through direct and strategic partnership channels.

Classification. NobleOak Life Ltd is classified under the Financials economic sector, Insurance business sector, and Life & Health Insurance industry with a confidence level of 0.92.

NobleOak Life Ltd maintains a strong liquidity position, with cash and equivalents amounting to AUD 85.55 million, representing 15.07% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is 0.019, which is above the industry median of 0.015, indicating a robust ability to meet short-term obligations. The debt-to-equity ratio of 0.05 is significantly lower than the industry median of 0.25, suggesting a conservative capital structure with minimal leverage risk. Profitability metrics show a return on equity (ROE) of 8.0%, which is below the industry median of 10.5%, and a return on assets (ROA) of 1.25%, also below the industry median of 2.0%. These figures suggest that the company is generating returns, but at a slower pace compared to its peers. The operating margin of 2.72% is in line with the industry median of 2.6%, indicating that the company is managing its operating costs effectively. The company's revenue is distributed across three segments: Direct Business, Partnership, and Genus. The Direct Business segment, which sells life insurance products directly to customers under the NobleOak brand, is the largest contributor to revenue. The Partnership segment, which sells products through advisors under partner brands, and the Genus segment, which provides administration services, also contribute to the revenue mix. The geographic exposure is primarily concentrated in Australia, with no significant international operations disclosed. Looking at the growth trajectory, the company is projected to see a 4.5% increase in revenue in the current fiscal year and a 3.2% increase in the next fiscal year. This growth is driven by expansion in the Direct Business segment and continued performance in the Partnership segment. The company's operating income is expected to grow by 3.8% in the current fiscal year and 2.9% in the next fiscal year, reflecting a stable but moderate growth outlook. The risk assessment indicates a low liquidity risk, supported by the company's strong cash reserves and low debt levels. The dilution risk is also low, with no immediate filing-based liquidity or dilution flags detected. The company has not issued new shares recently, and there are no indications of near-term dilution pressure. The conservative capital structure and strong liquidity position further mitigate the risk of financial distress. Recent events include the company's continued focus on expanding its Direct Business segment and maintaining strong relationships with strategic partners. The company has not disclosed any major regulatory changes or legal challenges that could impact its operations. Analysts have provided a mean price target of AUD 2.93, with a median of AUD 2.85, indicating a generally positive outlook despite the absence of strong-buy recommendations.
Key takeaways
  • NobleOak Life Ltd has a conservative capital structure with a low debt-to-equity ratio of 0.05, significantly below the industry median of 0.25.
  • The company's liquidity position is strong, with cash and equivalents representing 15.07% of total assets.
  • Return on equity (ROE) of 8.0% is below the industry median of 10.5%, indicating room for improvement in profitability.
  • The company is projected to see moderate revenue growth of 4.5% in the current fiscal year and 3.2% in the next fiscal year.
  • Analysts have provided a generally positive outlook, with a mean price target of AUD 2.93 and a median of AUD 2.85.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income$15.4M
Net income$7.1M
R&D
SG&A
D&A
SBC
Operating cash flow$58.7M
CapEx-$109.0k
Free cash flow$9.1M
Total assets$567.3M
Total liabilities$478.4M
Total equity$88.9M
Cash & equivalents$85.5M
Long-term debt$4.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$88.9M
Net cash$81.0M
Current ratio
Debt/Equity0.1
ROA1.2%
ROE8.0%
Cash conversion8.2%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
MetricNOLActivity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity5.0%48.5% medp25 43.7% · p75 53.3%bottom quartile
Observations
IR observations
Mean price target2.93 AUD
Median price target2.85 AUD
High price target3.30 AUD
Low price target2.63 AUD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.22 AUD
Last actual EPS0.20 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 07:39 UTC#682d3976
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 07:41 UTCJob: 1fe724c9